← Back to headlines
BTIG Upgrades MiniMed Group Stock Target Based on Pipeline Progress
Research firm BTIG has increased its price target for MiniMed Group, citing positive developments and progress within the company's clinical development pipeline.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Asian Markets Fall and Oil Prices Rise Amid Escalating US-Iran Tensions
46m ago
US Treasury Secretary Urges Bank of Japan to Maintain Sound Monetary Policy Amid Yen Volatility
2h ago
Apple Sets Executive Pay for New CEO John Ternus and Chair Tim Cook
2h ago
BOJ to debate rate rise, inflation much closer to 2% target: governor
2h ago